KRT5 and breast carcinoma: Clinically, basal-like breast cancer is characterized as the triple-negative phenotype (ER, PR, HER2, all negative) and as resembling stem-like cells, composed mainly of cells expressing the cancer stem cell markers CD44+ and cytokeratin 5/6 [31-33].